Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01317-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Taylor Morrisette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University…. Hauptthemen laut MEDLINE: Rifampin, Staphylococcal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Paratek Pharmaceuticals.
Abstract (Originalsprache)
Biofilm-associated infections lead to substantial morbidity. Omadacycline (OMC) is a novel aminomethylcycline with potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis , but data surrounding its use in biofilm-associated infections are lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
- Division of Infectious Diseases, Department of Medicine, Wayne State University, Detroit, Michigan, USA.
- Department of Pharmacy, Detroit Receiving Hospital, Detroit, Michigan, USA.
ORCID-Profile: Taylor Morrisette, Michael J Rybak
Förderung
- NIAID NIH HHS
- Paratek Pharmaceuticals
Zitieren
APA
Morrisette, T., Stamper, K. C., Lev, K. L., Kebriaei, R., Holger, D. J., Abdul-Mutakabbir, J. C., Kunz Coyne, A. J., & Rybak, M. J. (2023). Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01317-22
Vancouver
Morrisette T, Stamper KC, Lev KL, Kebriaei R, Holger DJ, Abdul-Mutakabbir JC, et al. Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01317-22
BibTeX
@article{Morrisette2023,
author = {Morrisette, Taylor and Stamper, Kyle C and Lev, Katherine L and Kebriaei, Razieh and Holger, Dana J and Abdul-Mutakabbir, Jacinda C and Kunz Coyne, Ashlan J and Rybak, Michael J},
title = {Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01317-22}
}
EUVIMED